XTX Topco »

Rapt Therapeutics shares owned by XTX Topco

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by XTX Topco from 13F filings

Historical chart of XTX Topco investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by XTX Topco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by XTX Topco

Quarter filed Position value Share count Share price at filing
2025-12-31 $616k 18k 33.87

More positions owned by XTX Topco

Procter & Gamble Company (PG)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Cme (CME)
Kroger (KR)
At&t (T)
Vanguard Index Fds Total Stk Mkt (VTI)
Metropcs Communications (TMUS)
First Ctzns Bancshares Inc D Cl A (FCNCA)
S&p Global (SPGI)
Albertsons Cos Common Stock (ACI)
O'reilly Automotive (ORLY)
Owl Rock Capital Corporation (OBDC)

View all positions for XTX Topco

Top funds holding Rapt Therapeutics

TCG Crossover Management
Fcpm Iii Services B.v.
OrbiMed Advisors
Rtw Investments
Foresite Capital Management VI
Siren
Vanguard Group
Frazier Life Sciences Management
Ikarian Capital
Braidwell
Soleus Capital Management
Nantahala Capital Management
Caligan Partners
State Street Corporation
Dr. Jeffrey R. Jay, M.D.

View all funds holding Rapt Therapeutics